Basal Insulin Formulations for the Management of Type 2 Diabetes

Details

Files
Project Status:
Completed
Project Line:
Reference List
Project Sub Line:
Summary of Abstracts
Project Number:
RB1548-000

Question

  1. What is the comparative risk of hypoglycemia in patients receiving various basal insulin formulations for the management of type 2 diabetes?

Key Message

Four systematic reviews (2 with meta-analyses and 2 with network meta-analyses), 22 randomized controlled trials, and 10 non-randomized studies were identified regarding the comparative risk of hypoglycemia in patients receiving various basal insulin formulations for the management of type 2 diabetes.